Cite

HARVARD Citation

    Phung, M. et al. (n.d.). AB0939 Off-label secukinumab dose escalation in the treatment of moderate-to-severe psoriasis: a multicenter, retrospective study. Annals of the rheumatic diseases. p. 1594. [Online]. 
  
Back to record